First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Short Interest Up 100.0% in December

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the target of a significant growth in short interest in December. As of December 15th, there was short interest totalling 400 shares, a growth of 100.0% from the November 30th total of 200 shares. Based on an average daily volume of 2,900 shares, the short-interest ratio is currently 0.1 days.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

First Trust Nasdaq Pharmaceuticals ETF stock traded down $0.15 during midday trading on Friday, reaching $27.24. The company had a trading volume of 1,314 shares, compared to its average volume of 4,948. First Trust Nasdaq Pharmaceuticals ETF has a 12-month low of $25.73 and a 12-month high of $29.72. The company has a market capitalization of $16.34 million, a P/E ratio of 15.98 and a beta of 0.70. The firm’s fifty day simple moving average is $27.95 and its 200-day simple moving average is $28.25.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The company also recently declared a dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Friday, December 13th will be paid a $0.1304 dividend. The ex-dividend date of this dividend is Friday, December 13th. This is a positive change from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13.

Institutional Trading of First Trust Nasdaq Pharmaceuticals ETF

An institutional investor recently bought a new position in First Trust Nasdaq Pharmaceuticals ETF stock. International Assets Investment Management LLC bought a new position in shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 2,662 shares of the company’s stock, valued at approximately $73,000. International Assets Investment Management LLC owned about 0.41% of First Trust Nasdaq Pharmaceuticals ETF at the end of the most recent reporting period.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.